FDA approves first liquid biopsy NGS companion diagnostic. This marks the first approval to combine these two technologies — NGS and liquid biopsy — in one diagnostic test in order to guide treatment decisions. FDA approves first liquid biopsy NGS companion diagnostic. This marks the first approval to combine these two technologies — NGS and liquid biopsy — in one diagnostic test in order to guide treatment decisions.

Content Original Link:

http://www.fda.gov/news-events/press-announcements/fda-approves-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test